Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

An SI Board Since May 1998

Posts	SubjectMarks	Bans	Symbol
1722	54	0	PFE

Emcee: Sonki	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1272	Monsanto Says Celebrex Drug Price Matches Competitors (Update2) Bloomber	Anthony Wong	-	1/4/1999
1271	Report of Kiplingers mention of some "miracle biotechs": messages.yah	Mel Spivak	-	1/4/1999
1270	Today's Philadelphia Inquirer and WSJ review mergers in 1998. Details linke	Henry Niman	-	1/4/1999
1269	just surfing and "celebrex" caught my eye? look up this company ca	n.p.	-	1/2/1999
1268	Celebrex was approved today, but label still considers it a NSAID. Details in N	Henry Niman	-	12/31/1998
1267	I don't think it is new information, but... Tonight on NIGHTLINE: A report	margie	-	12/23/1998
1266	Eugene Peroni, analyst of Janney Montgomery Scott picked WLA as one of 10 best	Anthony Wong	-	12/23/1998
1265	ML :This week's Focus 1 is:Company Name: Genentech Symbol / Exchange: GNE	Sonki	-	12/22/1998
1264	The morning WSJ has extensive Corporate Focus reports on AMGN and JNJ, post arb	Henry Niman	-	12/22/1998
1263	Merck & Co (MRK) & BMY > > > AXYS PHARMACEUTICALS INC and	Sonki	-	12/21/1998
1262	Tomorrow's Circulation will have a review on the benefits of CP IIb/IIIa in	Henry Niman	-	12/21/1998
1261	Pfizer's Viagra Receives Initial Approval in Japan (Update2) Bloombe	Anthony Wong	-	12/21/1998
1260	Lilly Boosts Dividend 15% to 23 Cents a Shr as Drug Sales Rise Bloomberg	Anthony Wong	-	12/21/1998
1259	Joe Kernan just gave an analysis of the NESP decision (said that Epogen was #1	Henry Niman	-	12/21/1998
1258	On Firday, DJ carried a smartmoney review on AHP which was call a "cheap d	Henry Niman	-	12/21/1998
1257	Friday AMGN won its dispute with JNJ over rights to a new and improved EPO (AMG	Henry Niman	-	12/21/1998
1256	AMGN has received a favorable arbitration ruling on its dispute with JNJ over E	Henry Niman	-	12/18/1998
1255	Important Eisinger article at thestreet.com Top Stor	aknahow	-	12/17/1998
1254	Today's NY Times has a major article on lack of funding for Biotechs and co	Henry Niman	-	12/16/1998
1253	Any reason as to why they cut Schering??	muddphudd	-	12/16/1998
1252	BioCentury has a review on diabetes treatments in clinical trials. Details lin	Henry Niman	-	12/16/1998
1251	Reuters, Tuesday, December 15, 1998 at	Danny Hayden	-	12/15/1998
1250	Schering-Plough:Hepatitis C treatment: not much on this thread about the approv	Ibnbatutaa	-	12/14/1998
1249	Lilly gets FDA OK to expand Evista labeling Monday December 14, 4:13 pm Eastern	Anthony Wong	-	12/14/1998
1248	Immunex Corp. Reiterated 'Buy' at Adams, Harkness Bloomberg News	Anthony Wong	-	12/14/1998

Go to reply# or date (mm/dd/yy):